SCHEMBL4764778

SCHEMBL4764778

O=CCc1c(-c2ccccc2)noc1C1CC1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
NR1H4 Q96RI1 9/20 0.39
FABP1 P07148 5/20 0.39
HSD17B13 Q7Z5P4 2/20 0.39
HIF1A Q16665 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
FFAR4 Q5NUL3 1/20 0.38
GABRA5 P31644 3/20 0.38
FABP4 P15090 1/20 0.38
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
KMT2A Q03164 1/20 0.37
PKM P14618 1/20 0.36
FFAR2 O15552 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27729510 0.81 PTGS1 (0.40) ALDH1A1NR1H4FABP1HSD17B13NPSR1
SCHEMBL23906961 0.81 NOTUM (0.45) ALDH1A1NR1H4FABP1HSD17B13HIF1A
SCHEMBL26870513 0.81 GABRA5 (0.40) ALDH1A1NR1H4FABP1HSD17B13NPSR1
SCHEMBL27732988 0.80 FFAR4 (0.39) NR1H4FABP1HSD17B13FFAR4GABRA5
SCHEMBL22789944 0.80 NR1H4 (0.53) NR1H4FABP1HSD17B13FABP4
SCHEMBL4723502 0.79 ALDH1A1 (0.56) ALDH1A1NPSR1GABRA5MEN1KMT2A
SCHEMBL22790072 0.78 NR1H4 (0.55) NR1H4
SCHEMBL22789989 0.76 NR1H4 (0.59) NR1H4HSD17B13
SCHEMBL22790026 0.74 PPARG (0.45) ALDH1A1NR1H4FABP1HSD17B13MEN1
SCHEMBL4974872 0.74 PTGS2 (0.58) ALDH1A1NPSR1FFAR4GABRA5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979350-A1 ARYL-ISOXAZOL-4-YL-IMIDAZO[1,2-A]PYRIDINE USEFUL FOR THE TREATMENT OF ALZHEIMER'S DISEASE VIA GABA RECEPTORS F.HOFFMANN-LA ROCHE AG (CH) 2008-10-15 EP disclosed
EP-1968973-A2 ARYL-ISOXAZOL-4-YL-IMIDAZOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2008-09-17 EP disclosed
WO-2007082806-A1 ARYL-ISOXAZOL-4-YL-IMIDAZO[1,2-A]PYRIDINE USEFUL FOR THE TREATMENT OF ALZHEIMER’S DISEASE VIA GABA RECEPTORS F. HOFFMANN-LA ROCHE AG (CH) 2007-07-26 WO disclosed
WO-2007074078-A2 ARYL-ISOXAZOL-4-YL-IMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-07-05 WO disclosed